FOLH1 and posterior cortical atrophy: While PSMA cannot reliably distinguish canine PCA from iUC, its broad expression by uroepithelial carcinomas keeps the door open for future research studies related to PSMA-targeting strategies that include molecular imaging and small molecule inhibitors.